TrialThe British journal of ophthalmology2025

Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine.

Noemi Guemes-Villahoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.